Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma.Published in:British Journal of Haematology, 2022, v. 199, n. 1, p. 95, doi. 10.1111/bjh.18298By:Abeykoon, Jithma P.;Vaxman, Julia;Patel, Sanjay V.;Kumar, Shaji;Malave, Gabriella C.;Young, Kimberly S.;Ailawadhi, Sikander;Larsen, Jeremy T.;Dispenzieri, Angela;Muchtar, Eli;Gonsalves, Wilson I.;Kourelis, Taxiarchis;Leung, Nelson;Warsame, Rahma;Go, Ronald S.;Bergsagel, Leif;Lacy, Martha Q.;Rajkumar, S. Vincent;Gertz, Morie A.;Kapoor, PrashantPublication type:Article